Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.
Cancer Cell Int. 2023 Oct 21;23(1):248. doi: 10.1186/s12935-023-03079-2.
Cancer Cell Int. 2023.
PMID: 37865750
Free PMC article.
STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
Chen J, Huang S, Li H, Li Y, Zeng H, Hu J, Lin Y, Cai H, Deng P, Song T, Guan T, Zeng H, Liu M.
Chen J, et al.
Clin Transl Oncol. 2023 Mar;25(3):662-672. doi: 10.1007/s12094-022-02970-0. Epub 2022 Nov 24.
Clin Transl Oncol. 2023.
PMID: 36422798
Item in Clipboard
Cite
Cite